NWL
44
-4
IFF
53
2
ZBH
60
-2
FLS
73
-2
AIG
38
-4
DHI
48
3
VRTX
46
2
ALLE
37
5
HSIC
54
-3
XOM
47
5
NAVI
41
-3
CAG
30
4
WAT
47
5
IBM
54
4
C
58
-2
TEL
60
2
XEL
67
2
HON
65
-2
LH
42
2
PEP
41
6
NWL
44
-4
IFF
53
2
ZBH
60
-2
FLS
73
-2
AIG
38
-4
DHI
48
3
VRTX
46
2
ALLE
37
5
HSIC
54
-3
XOM
47
5
NAVI
41
-3
CAG
30
4
WAT
47
5
IBM
54
4
C
58
-2
TEL
60
2
XEL
67
2
HON
65
-2
LH
42
2
PEP
41
6
Financhill
Back

Evaxion Biotech AS 10K Form

Sell
1

EVAX
Evaxion Biotech AS

Last Price:
1.37
Seasonality Move:
-40.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVAX News And Ratings

See the #1 stock for the next 7 days that we like better than EVAX

EVAX Financial Statistics

Sales & Book Value

Annual Sales: $73K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.01
Price / Book: 122.87

Profitability

EPS (TTM): -2.80000
Net Income (TTM): $-11.46M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -69.51%

Evaxion Biotech AS Earnings Forecast

Key Evaxion Biotech AS Financial Ratios

  • The Research & Development expenses have been 16,323.29% of Revenue.
  • The Interest Expense is -4.05% of Operating Income.
  • The Net Earning history of EVAX is -30,308.22% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Evaxion Biotech AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EVAX
Website: evaxion-biotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EVAX Technical Analysis vs Fundamental Analysis

Sell
1
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy or a Sell?